Arvinas Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$10.64

+0.35 (+3.40%)

As of Mar 25, 2:16 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 16 62%

Hold 9 35%

Sell 1 4%

Price Target

Analyst Price Target +522.4% upside

Low Target $44.47

Average Target $66.22

High Target $75.30

Current Price $10.64

Current
$10.64

Target
$66.22

$44.47 $66.22 avg $75.30

Scenario Analysis

Bear Case

$44.47

318.0%

Low target

Base Case

$66.22

+522.4%

Avg target

Bull Case

$75.30

+607.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$14.51

-26.7% from high

52-Week Low

$5.90

+80.3% from low

Target vs 52W High

$66.22

+356.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%